4.0
May 27, 2025
Current employee, more than 3 years
Tarrytown, NY
Recommend
CEO approval
Business outlook
Pros
lots of opportunities to learn and develop, leading drug development pipeline
Cons
Suboptimal compensation, goal of innovative science is bogged down by bureaucracy, slightly cultish company culture